Cargando…

Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention

OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years o...

Descripción completa

Detalles Bibliográficos
Autores principales: Harper, Diane M., Irons, Billy B., Alexander, Natalie M., Comes, Johanna C., Smith, Melissa S., Heutinck, Melinda A., Handley, Sandra M., Ahern, Debra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925140/
https://www.ncbi.nlm.nih.gov/pubmed/24551110
http://dx.doi.org/10.1371/journal.pone.0088493
_version_ 1782303817989095424
author Harper, Diane M.
Irons, Billy B.
Alexander, Natalie M.
Comes, Johanna C.
Smith, Melissa S.
Heutinck, Melinda A.
Handley, Sandra M.
Ahern, Debra A.
author_facet Harper, Diane M.
Irons, Billy B.
Alexander, Natalie M.
Comes, Johanna C.
Smith, Melissa S.
Heutinck, Melinda A.
Handley, Sandra M.
Ahern, Debra A.
author_sort Harper, Diane M.
collection PubMed
description OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years old completed a decisional satisfaction survey about their HPV vaccine experience. RESULTS: Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses. CONCLUSIONS: Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination.
format Online
Article
Text
id pubmed-3925140
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39251402014-02-18 Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention Harper, Diane M. Irons, Billy B. Alexander, Natalie M. Comes, Johanna C. Smith, Melissa S. Heutinck, Melinda A. Handley, Sandra M. Ahern, Debra A. PLoS One Research Article OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years old completed a decisional satisfaction survey about their HPV vaccine experience. RESULTS: Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses. CONCLUSIONS: Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination. Public Library of Science 2014-02-14 /pmc/articles/PMC3925140/ /pubmed/24551110 http://dx.doi.org/10.1371/journal.pone.0088493 Text en © 2014 Harper et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Harper, Diane M.
Irons, Billy B.
Alexander, Natalie M.
Comes, Johanna C.
Smith, Melissa S.
Heutinck, Melinda A.
Handley, Sandra M.
Ahern, Debra A.
Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title_full Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title_fullStr Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title_full_unstemmed Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title_short Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
title_sort quantifying the decisional satisfaction to accept or reject the human papillomavirus (hpv) vaccine: a preference for cervical cancer prevention
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925140/
https://www.ncbi.nlm.nih.gov/pubmed/24551110
http://dx.doi.org/10.1371/journal.pone.0088493
work_keys_str_mv AT harperdianem quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT ironsbillyb quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT alexandernataliem quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT comesjohannac quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT smithmelissas quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT heutinckmelindaa quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT handleysandram quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention
AT aherndebraa quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention